{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T03:21:07Z","timestamp":1781839267517,"version":"3.54.5"},"reference-count":36,"publisher":"The Endocrine Society","issue":"12","license":[{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Prolactin (PRL) is a crucial mediator of glucoinsulinemic metabolism.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>This work aims to dissect glucose metabolism during and after pregnancy in patients with prolactinomas.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A total of 52 patients treated with cabergoline (CAB) were evaluated before conception, during pregnancy, and up to 10 years after delivery. During pregnancy, CAB was discontinued, while it was restarted in 57.7% of patients after delivery, due to recurrent hyperprolactinemia (RH). Hormonal (serum PRL) and metabolic (glycated hemoglobin A1c [HbA1c], fasting glucose [FG], glucose tolerance) parameters were assessed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>During pregnancy, PRL gradually increased, while FG remained stable. An inverse correlation between PRL and FG was found in the first (P = .032) and third (P = .048) trimester. PRL percentage increase across pregnancy was inversely correlated with third-trimester FG. Serum PRL before conception emerged as a predictive biomarker of third-trimester FG (t = 2.603; P = .048). Older patients with lower HbA1c in the first trimester and lower FG at 3 years post partum delivered infants with reduced birth weight. Breastfeeding up to 6 months correlated with lower FG at 4 and 10 years post partum. A positive correlation between BMI and FG at 10 years after delivery (P = .03) was observed, particularly in overweight\/obese patients requiring higher CAB doses. Patients with RH who had to restart CAB showed shorter breastfeeding duration and higher FG at 2 years post partum.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Low PRL levels before pregnancy may be detrimental to FG during pregnancy. CAB duration and dose may influence long-term glucose tolerance, besides family history and BMI. Preconception metabolic management should be recommended to reduce the risk of gestational and type 2 diabetes mellitus.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgae289","type":"journal-article","created":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T06:41:03Z","timestamp":1714632063000},"page":"3245-3253","source":"Crossref","is-referenced-by-count":7,"title":["Risk Assessment of Diabetes Mellitus During and After Pregnancy in Women With Prolactinomas"],"prefix":"10.1210","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7353-8437","authenticated-orcid":false,"given":"Roberta","family":"Scairati","sequence":"first","affiliation":[{"name":"Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Diabetologia, Andrologia e Nutrizione, Universit\u00e0 Federico II di Napoli , 80131, Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata S","family":"Auriemma","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Diabetologia, Andrologia e Nutrizione, Universit\u00e0 Federico II di Napoli , 80131, Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Di Meglio","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Diabetologia, Andrologia e Nutrizione, Universit\u00e0 Federico II di Napoli , 80131, Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guendalina","family":"Del Vecchio","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Diabetologia, Andrologia e Nutrizione, Universit\u00e0 Federico II di Napoli , 80131, Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1272-9328","authenticated-orcid":false,"given":"Rosa","family":"Pirchio","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Diabetologia, Andrologia e Nutrizione, Universit\u00e0 Federico II di Napoli , 80131, Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Graziadio","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Diabetologia, Andrologia e Nutrizione, Universit\u00e0 Federico II di Napoli , 80131, Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Pivonello","sequence":"additional","affiliation":[{"name":"Dipartimento di Sanit\u00e0 Pubblica, Universit\u00e0 Federico II di Napoli , 80131, Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9632-1348","authenticated-orcid":false,"given":"Rosario","family":"Pivonello","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Diabetologia, Andrologia e Nutrizione, Universit\u00e0 Federico II di Napoli , 80131, Naples ,","place":["Italy"]},{"name":"UNESCO Chair for Health Education and Sustainable Development, Universit\u00e0 Federico II , 80131, Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6986-266X","authenticated-orcid":false,"given":"Annamaria","family":"Colao","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Diabetologia, Andrologia e Nutrizione, Universit\u00e0 Federico II di Napoli , 80131, Naples ,","place":["Italy"]},{"name":"UNESCO Chair for Health Education and Sustainable Development, Universit\u00e0 Federico II , 80131, Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,5,2]]},"reference":[{"issue":"4","key":"2024111804010950100_dgae289-B1","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1210\/endo.143.4.8722","article-title":"Targeted deletion of the PRL receptor: effects on islet development, insulin production, and glucose tolerance","volume":"143","author":"Freemark","year":"2002","journal-title":"Endocrinology"},{"issue":"6","key":"2024111804010950100_dgae289-B2","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41574-019-0194-6","article-title":"Prolactin\u2014a pleiotropic factor in health and disease","volume":"15","author":"Bernard","year":"2019","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"2024111804010950100_dgae289-B3","doi-asserted-by":"crossref","first-page":"E1309","DOI":"10.1152\/ajpendo.00636.2012","article-title":"Defective prolactin signaling impairs pancreatic \u03b2-cell development during the perinatal period","volume":"305","author":"Auffret","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6","key":"2024111804010950100_dgae289-B4","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-2007-979040","article-title":"Adaptation of islets of Langerhans to pregnancy: beta-cell growth, enhanced insulin secretion and the role of lactogenic hormones","volume":"29","author":"Sorenson","year":"1997","journal-title":"Horm Metab Res"},{"issue":"8","key":"2024111804010950100_dgae289-B5","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.2337\/db15-1527","article-title":"Gestational diabetes Mellitus from inactivation of prolactin receptor and MafB in islet \u03b2-cells","volume":"65","author":"Banerjee","year":"2016","journal-title":"Diabetes"},{"issue":"4","key":"2024111804010950100_dgae289-B6","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1210\/en.2008-1003","article-title":"Prolactin receptor is required for normal glucose homeostasis and modulation of beta-cell mass during pregnancy","volume":"150","author":"Huang","year":"2009","journal-title":"Endocrinology"},{"key":"2024111804010950100_dgae289-B7","doi-asserted-by":"crossref","first-page":"1001703","DOI":"10.3389\/fendo.2022.1001703","article-title":"The beneficial metabolic actions of prolactin","volume":"13","author":"Macotela","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"2024111804010950100_dgae289-B8","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1007\/s40618-023-02101-8","article-title":"Low prolactin level identifies hypoactive sexual desire disorder women with a reduced inhibition profile","volume":"46","author":"Maseroli","year":"2023","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2024111804010950100_dgae289-B9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s12020-022-03145-1","article-title":"Cardiometabolic profile of young women with hypoprolactinemia","volume":"78","author":"Krysiak","year":"2022","journal-title":"Endocrine"},{"issue":"3","key":"2024111804010950100_dgae289-B10","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1530\/EJE-20-0144","article-title":"Maternal prolactin is associated with glucose status and PCOS in pregnancy: odense child cohort","volume":"183","author":"Overgaard","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2024111804010950100_dgae289-B11","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.2337\/dc16-0043","article-title":"Maternal Serum prolactin and prediction of postpartum \u03b2-cell function and risk of prediabetes\/diabetes","volume":"39","author":"Retnakaran","year":"2016","journal-title":"Diabetes Care"},{"key":"2024111804010950100_dgae289-B12","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3389\/fendo.2019.00327","article-title":"Glucose abnormalities associated to prolactin secreting pituitary adenomas","volume":"10","author":"Auriemma","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2024111804010950100_dgae289-B13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fendo.2020.00083","article-title":"Plasma prolactin and progesterone levels and the risk of gestational diabetes: a prospective and longitudinal study in a multiracial cohort","volume":"11","author":"Li","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2024111804010950100_dgae289-B14","doi-asserted-by":"crossref","first-page":"1069625","DOI":"10.3389\/fendo.2022.1069625","article-title":"Prolactin in relation to gestational diabetes and metabolic risk in pregnancy and postpartum: a systematic review and meta-analysis","volume":"13","author":"Rassie","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"2024111804010950100_dgae289-B15","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1055\/s-0031-1284353","article-title":"Prolactin and lactation as modifiers of diabetes risk in gestational diabetes","volume":"43","author":"Ramos-Rom\u00e1n","year":"2011","journal-title":"Horm Metab Res"},{"issue":"12","key":"2024111804010950100_dgae289-B16","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.2174\/1871530323666230511104045","article-title":"Italian guidelines for the management of prolactinomas","volume":"23","author":"Cozzi","year":"2023","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"12","key":"2024111804010950100_dgae289-B17","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","article-title":"Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement","volume":"19","author":"Petersenn","year":"2023","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"2024111804010950100_dgae289-B18","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1210\/jc.2012-3039","article-title":"Results of a single-center observational 10-year survey study on recurrence of hyperprolactinemia after pregnancy and lactation","volume":"98","author":"Auriemma","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2024111804010950100_dgae289-B19","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1530\/EJE-13-0231","article-title":"Safety of long-term treatment with cabergoline on cardiac valve disease in patients with prolactinomas","volume":"169","author":"Auriemma","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"2024111804010950100_dgae289-B20","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.numecd.2017.06.010","article-title":"Italian national guidelines for the screening of gestational diabetes: time for a critical appraisal?","volume":"27","author":"Bianchi","year":"2017","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"3","key":"2024111804010950100_dgae289-B21","doi-asserted-by":"crossref","first-page":"676","DOI":"10.2337\/dc09-1848","article-title":"International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy","volume":"33","author":"International Association of Diabetes and Pregnancy Study Groups Consensus Panel","year":"2010","journal-title":"Diabetes Care"},{"issue":"9","key":"2024111804010950100_dgae289-B22","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.2337\/dc23-ad08","article-title":"Addendum. 2. Classification and diagnosis of diabetes: standards of care in diabetes-2023. Diabetes care 2023;46(suppl. 1):s19\u2013S40","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"issue":"2","key":"2024111804010950100_dgae289-B23","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.diabres.2013.11.003","article-title":"Global estimates of the prevalence of hyperglycaemia in pregnancy","volume":"103","author":"Guariguata","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"2024111804010950100_dgae289-B24","doi-asserted-by":"publisher","first-page":"e14190","DOI":"10.1111\/eci.14190","article-title":"Prolactin effects on the pathogenesis of diabetes mellitus","author":"Scairati","year":"2024","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"2024111804010950100_dgae289-B25","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1113\/jphysiol.2007.146316","article-title":"From feeding one to feeding many: hormone-induced changes in bodyweight homeostasis during pregnancy","volume":"586","author":"Augustine","year":"2008","journal-title":"J Physiol"},{"issue":"1","key":"2024111804010950100_dgae289-B26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000459633","article-title":"Metabolic adaptations in pregnancy: a review","volume":"70","author":"Zeng","year":"2017","journal-title":"Ann Nutr Metab"},{"issue":"11","key":"2024111804010950100_dgae289-B27","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.2337\/dc08-1111","article-title":"Pregnancy insulin, glucose, and BMI contribute to birth outcomes in nondiabetic mothers","volume":"31","author":"Ong","year":"2008","journal-title":"Diabetes Care"},{"issue":"19","key":"2024111804010950100_dgae289-B28","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","article-title":"Hyperglycemia and adverse pregnancy outcomes","volume":"358","author":"HAPO Study Cooperative Research Group","year":"2008","journal-title":"N Engl J Med"},{"issue":"3","key":"2024111804010950100_dgae289-B29","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.tem.2006.02.005","article-title":"Focus on prolactin as a metabolic hormone","volume":"17","author":"Ben-Jonathan","year":"2006","journal-title":"Trends Endocrinol Metab"},{"issue":"11","key":"2024111804010950100_dgae289-B30","doi-asserted-by":"crossref","first-page":"e12888","DOI":"10.1111\/jne.12888","article-title":"Metabolic functions of prolactin: physiological and pathological aspects","volume":"32","author":"Lopez-Vicchi","year":"2020","journal-title":"J Neuroendocrinol"},{"issue":"5","key":"2024111804010950100_dgae289-B31","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1093\/ajcn\/nqab206","article-title":"Breastfeeding and risk of overweight in childhood and beyond: a systematic review with emphasis on sibling-pair and intervention studies","volume":"114","author":"Dewey","year":"2021","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"2024111804010950100_dgae289-B32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11892-019-1121-x","article-title":"Breastfeeding and type 2 diabetes: systematic review and meta-analysis","volume":"19","author":"Horta","year":"2019","journal-title":"Curr Diab Rep"},{"issue":"5","key":"2024111804010950100_dgae289-B33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrendo.2011.37","article-title":"Medical treatment of prolactinomas","volume":"7","author":"Colao","year":"2011","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"2024111804010950100_dgae289-B34","doi-asserted-by":"crossref","first-page":"22347","DOI":"10.1038\/s41598-020-79292-0","article-title":"Central dopamine D2 receptors regulate plasma glucose levels in mice through autonomic nerves","volume":"10","author":"Ikeda","year":"2020","journal-title":"Sci Rep"},{"issue":"4","key":"2024111804010950100_dgae289-B35","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000357810","article-title":"Effect of cabergoline on metabolism in prolactinomas","volume":"98","author":"Auriemma","year":"2013","journal-title":"Neuroendocrinology"},{"issue":"6","key":"2024111804010950100_dgae289-B36","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/cen.12204","article-title":"Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levels","volume":"79","author":"Ciresi","year":"2013","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgae289\/57570031\/dgae289.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/12\/3245\/60680329\/dgae289.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/109\/12\/3245\/60680329\/dgae289.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,18]],"date-time":"2024-11-18T04:01:38Z","timestamp":1731902498000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/109\/12\/3245\/7661012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,2]]},"references-count":36,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,5,2]]},"published-print":{"date-parts":[[2024,11,18]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgae289","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,5,2]]}}}